Nonsteroidal Anti-inflammatory Drugs and Neutropenia

Archives of Internal Medicine

Volumn 153, Issue 18, 1993, Pages 2119-2124

  Strom, Brian L ^a   Carson, Jeffrey L ^a,b   Schinnar, Rita ^a   Snyder, Ellen Sim ^a   Shaw, Michele ^c   Lundin, Frank E ^d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c Department of Post Marketing Surveillance Health Information Designs Inc ^*  (United States)

^d CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; OXYPHENBUTAZONE; PHENYLBUTAZONE;

ADOLESCENT; ADULT; AGED; AGRANULOCYTOSIS; ARTICLE; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PRIORITY JOURNAL; RISK FACTOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMAN; INFANT; MALE; MIDDLE AGE; NEUTROPENIA; ODDS RATIO; PHENYLBUTAZONE; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027379250     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.1993.00410180065007     Document Type: Article

References (29)

1. Nelson CR. Drug utilization in office practice, National Ambulatory Medical Care Survey, 1990. In: Advance Data From Vital and Health Statistics. Hyattsville, Md: National Center for Health Statistics; 1993. Publication 232.
2. Inman WHW. Study of fatal bone marrow depression with special reference to phenylbutazone and oxyphenbutazone. BMJ. 1977;1:1500-1505.
3. Heimpel H. Drug-induced agranulocytosis. Med Toxicol. 1988;3:449-462.
4. Young GAR, Vincent PC. Drug-induced agranulocytosis. Clin Hematol. 1980; 9:483-504.
5. Hartl PW. Drug-induced agranulocytosis. In: Girdwood RH, ed. Blood Disorders due to Drugs and Other Agents. Amsterdam, the Netherlands: Excerpta Medica; 1973:147-186.
6. Arneborn P, Palmblad J. Drug-induced neutropenia in the Stockholm region, 1973-1975: frequency and causes. Acta Med Scand. 1978;204:283-286.
7. Bottiger LE, Westerholm B. Drug-induced blood dyscrasias in Sweden. BMJ. 1973;3:339-343.
8. Bottiger LE, Furhoff AK, Holmberg L. Drug-induced blood dyscrasias: a ten-year material from the Swedish Adverse Drug Reaction Committee. Acta Med Scand. 1979;205:457-461.
9. Danielson DA, Doublas SW, Herzog P, et al. Drug-induced blood disorers. JAMA. 1984;252:3257-3260.
10. Mason RM. Treatment of gout. Rep Rheum Dis. 1968;32:1-2.
11. Millinton D. Leucopenia and indomethacin. BMJ. 1966;1:49.
12. Girdwood RH. Death after taking medications. BMJ. 1974;1:501-504.
13. Kaziro GSN. Oral ulceration and neutropenia associated with naproxen. Aust Dent J. 1980;25:333-334.
14. Nygard N. Naproxen and agranulocytosis. JAMA. 1987;257:1732.
15. Gryfe CI, Rubensahl S. Agranulocytosis and aplastic anemia possibly due to ibuprofen. Can Med Assoc J. 1976;114:877.
16. Simon SD, Kesmin M. Fenoprofen and agranulocytosis. N Engl J Med. 1978; 299:490.
17. Sakai J, Joseph MW. Tolmetin and agranulocytosis. N Engl J Med. 1978;298: 1203.
18. International Agranulocytosis and Aplastic Anemia Study. The design of a study of the drug etiology of agranulocytosis and aplastic anernia. Eur J Clin Pharmacol. 1983;24:833-836.
19. International Agranulocytosis and Aplastic Anemia Study. Risks of agranulocytosis and aplastic anemia: a first report of their relation to drug use wih special reference to analgesics. JAMA. 1986;256:1749-1757.
20. International Agranulocytosis and Aplastic Anemia Study. Risk of agranulocytosis and aplastic anaemia in relation to use of antithyroid drugs. BMJ. 1988; 297:262-265.
21. Strom BL, Carson JL, Morse ML, LeRoy AA. The Computerized On-Line Medicaid Pharmaceutical Analysis and Surveillance System: a new resource for post-marketing drug surveillance. Clin Pharmacol Ther. 1985;38:359-364.
22. International Classification of Diseases, Ninth Revision, Clinical Modification. Ann Arbor, Mich: Commission on Professional and Hospital Activities; 1980.
23. Logue GL, Shimm DS. Autoimmune granulocytopenia. Ann Rev Med. 1980; 31:191-200.
24. Strom BL, Carson JL, Schinnar R, Snyder ES, Shaw M. Descriptive epidemiology of agranulocytosis. Arch Intern Med. 1992;152:1475-1480.
25. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic Research. Belmont, Calif: Lifetime Learning Publications; 1982:314-315.
26. Mauritsen B. EGRET. Seattle, Wash: Statistics and Epidemiology Research Corp; 1990.
27. Mantel N, Haenszel W. Statistical aspects of the analyses of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719-748.
28. Kleinbaum DG, Kupper LL. Applied Regression and Other Multivariable Methods. Boston, Mass: Duxbury Press; 1978.
29. Faich GA. Risks and indications of phenylbutazone: another look. Pharmacotherapy. 1987;7:25-27.